Table 2 Number of patients from each each treatment or early responder groups classified as Mode of action responders or non-responders.
Mode of action, non-responders (n = 353) | Mode of action, responders (n = 178) | |
|---|---|---|
Number on tocilizumab 8 mg/kg (%), n = 175 | 37 (7 %) | 138 (26 %) |
Number on tocilizumab 4 mg/kg (%), n = 175 | 146 (27 %) | 29 (5 %) |
Number on placebo (%), n = 181 | 170 (32 %) | 11 (2 %) |
Number of early responders | 228 (43 %) | 144 (27 %) |
Number of early non-responders | 125 (24 %) | 34 (6 %) |